Abstract
Urinary plasminogen activator (uPA) is a serine protease that plays important roles in various extracellular proteolytic processes. In humans, protein C inhibitor (PCI) is known to regulate the activity of the serine proteases involved in blood coagulation, wound healing, and tumor metastasis, whereas PCI is not present in murine plasma or tissues other than the reproductive tissues. The large amount of uPA–PCI complexes found in human urine suggests that these complexes are formed in the kidneys. In the present study, we performed immunofluorescence double labeling and electron microscopic immunocytochemistry using renal tissues from humans and human PCI gene transgenic (PCI-TG) mice. In human renal tissues, PCI and uPA colocalized in the cytoplasm of renal proximal tubular epithelial cells (RPTECs), and juxtaposition of PCI and uPA immunoreactive particles was detected in the microvilli and lysosomes in the RPTECs. The intracellular distributions of PCI and uPA in the RPTECs from PCI-TG mice were similar to those observed in human RPTECs. These findings hint at the physiological roles of uPA and PCI in human kidneys, and also suggest that the PCI-TG mice will be useful for evaluating the roles of PCI in human physiological and pathological conditions.
Abbreviations
- PCI:
-
Protein C inhibitor
- uPA:
-
Urinary plasminogen activator
- RPTECs:
-
Renal proximal tubular epithelial cells
References
Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I (2005) Expression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitro. Reprod Biol Endocrinol 3:7
Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1–22
Asanuma K, Yoshikawa T, Hayashi T, Akita N, Nakagawa N, Hamada Y, Nishioka J, Kamada H, Gabazza EC, Ido M, Uchida A, Suzuki K (2007) Protein C inhibitor inhibits breast cancer cell growth, metastasis, and angiogenesis independently of its protease inhibitory activity. Int J Cancer 121:955–965
Brown PA, Wilson HM, Reid FJ, Booth NA, Simpson JG, Morrison L, Power DA, Haites NE (1994) Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. Kidney Int 45:43–47
Cao Y, Becker C, Lundwall A, Christensson A, Gadaleanu V, Lilja H, Bjartell A (2003) Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues. Prostate 57:196–204
Carlin SM, Resink TJ, Tamm M, Roth M (2005) Urokinase signal transduction and its role in cell migration. FASEB J 19:195–202
Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129:307–321
Conese M, Blasi F (1995) Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation. Biol Chem Hoppe Seyler 376:143–155
Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10:39–49
Eddy AA (2002) Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 283:F209–F220
Espana F, Estelles A, Fernandez PJ, Gilabert J, Sanchez-Cuenca J, Griffin JH (1993) Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost 70:989–994
Florquin S, van den Berg JG, Olszyna DP, Claessen N, Opal SM, Weening JJ, van der Poll T (2001) Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int 59:2054–2061
Geiger M, Priglinger U, Griffin JH, Binder BR (1991) Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase. J Biol Chem 266:11851–11857
Hayashi T, Suzuki K (1993) Gene organization of human protein C inhibitor, a member of SERPIN family proteins encoded in five exons. Int J Hematol 58:213–224
Hayashi T, Nishioka J, Kamada H, Asanuma K, Kondo H, Gabazza EC, Ido M, Suzuki K (2004) Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J Thromb Haemost 2:949–961
Hayashi T, Nishioka J, Nakagawa N, Kamada H, Gabazza EC, Kobayashi T, Hattori A, Suzuki K (2007) Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator. J Thromb Haemost 5:1477–1485
Kasza A, Petersen HH, Heegaard CW, Oka K, Christensen A, Dubin A, Chan L, Andreasen PA (1997) Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein- receptor-related protein. Eur J Biochem 248:270–281
Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H (1992) Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 89:1094–1101
List K, Jensen ON, Bugge TH, Lund LR, Ploug M, Dano K, Behrendt N (2000) Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice. Biochemistry 39:508–515
Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, Stura EA, Menez A (2005) Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J 24:1655–1663
Ma N, Ding X, Doi M, Izumi N, Semba R (2004) Cellular and subcellular localization of heme oxygenase-2 in monkey retina. J Neurocytol 33:407–415
Marksitzer R, Stief A, Menoud PA, Nagamine Y (1995) Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene. J Biol Chem 270:21833–21838
Meijers JC, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, Bouma BN (1988) Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 27:4231–4237
Moestrup SK, Nielsen S, Andreasen P, Jorgensen KE, Nykjaer A, Roigaard H, Gliemann J, Christensen EI (1993) Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J Biol Chem 268:16564–16570
Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25:450–455
Palmieri D, Lee JW, Juliano RL, Church FC (2002) Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells. J Biol Chem 277:40950–40957
Petersen LC, Lund LR, Nielsen LS, Dano K, Skriver L (1988) One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem 263:11189–11195
Radtke KP, Fernandez JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH (1994) Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 94:2117–2124
Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP (2000) Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58:1841–1850
Rezaie AR, Cooper ST, Church FC, Esmon CT (1995) Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 270:25336–25339
Sappino AP, Huarte J, Vassalli JD, Belin D (1991) Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962–970
Schwartz BS, Espana F (1999) Two distinct urokinase-serpin interactions regulate the initiation of cell surface-associated plasminogen activation. J Biol Chem 274:15278–15283
Stief TW, Radtke KP, Heimburger N (1987) Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hoppe Seyler 368:1427–1433
Stump DC, Thienpont M, Collen D (1986) Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma. J Biol Chem 261:12759–12766
Suzuki K (2000) Protein C inhibitor (PAI-3): structure and multi-function. Fibrinol Proteol 14:133–145
Suzuki K, Nishioka J, Hashimoto S (1983) Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 258:163–168
Suzuki K, Nishioka J, Kusumoto H, Hashimoto S (1984) Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 95:187–195
Tanski WJ, Fegley AJ, Roztocil E, Davies MG (2004) Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg 39:214–222
Turner RB, Liu L, Sazonova IY, Reed GL (2002) Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. J Biol Chem 277:33068–33074
Van Leer C, Stutz M, Haeberli A, Geiser T (2005) Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro. Thromb Haemost 94:1257–1264
Vassalli JD, Baccino D, Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100:86–92
Vilhardt F, Nielsen M, Sandvig K, van Deurs B (1999) Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells. Mol Biol Cell 10:179–195
Wagner SN, Atkinson MJ, Wagner C, Hofler H, Schmitt M, Wilhelm O (1996) Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol 105:53–60
Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K (2004) Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 108:516–523
Watanabe M, Yano W, Kondo S, Hattori Y, Yamada N, Yanai R, Nishida T (2003) Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci 44:3332–3338
Zhai XY, Birn H, Jensen KB, Thomsen JS, Andreasen A, Christensen EI (2003) Digital three-dimensional reconstruction and ultrastructure of the mouse proximal tubule. J Am Soc Nephrol 14:611–619
Acknowledgments
This study was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS) (No. 17390276, 19390262), and a grant from the Mie University COE Project Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, Z., Ma, N., Hayashi, T. et al. Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice. Histochem Cell Biol 128, 293–300 (2007). https://doi.org/10.1007/s00418-007-0330-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-007-0330-6